118 related articles for article (PubMed ID: 37648302)
21. Impact of radiological morphology of clinical T1 renal cell carcinoma on the prediction of upstaging to pathological T3.
Teishima J; Hayashi T; Kitano H; Sadahide K; Sekino Y; Goto K; Inoue S; Honda Y; Sentani K; Awai K; Yasui W; Matsubara A
Jpn J Clin Oncol; 2020 Apr; 50(4):473-478. PubMed ID: 32100866
[TBL] [Abstract][Full Text] [Related]
22. Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria.
Hamilton ZA; Capitanio U; Pruthi D; Ghali F; Larcher A; Patel DN; Eldefrawy A; Patel S; Cotta BH; Bradshaw AW; Meagher MF; Miller NS; Carenzi C; Wan F; Liss MA; McGregor T; Montorsi F; Derweesh IH
Urology; 2020 Apr; 138():60-68. PubMed ID: 31836465
[TBL] [Abstract][Full Text] [Related]
23. Plasma fibrinogen level: an independent prognostic factor for disease-free survival and cancer-specific survival in patients with localised renal cell carcinoma.
Obata J; Tanaka N; Mizuno R; Kanao K; Mikami S; Matsumoto K; Kosaka T; Kikuchi E; Jinzaki M; Oya M
BJU Int; 2016 Oct; 118(4):598-603. PubMed ID: 26780664
[TBL] [Abstract][Full Text] [Related]
24. Significance of Pathologic T3a Upstaging in Clinical T1 Renal Masses Undergoing Nephrectomy.
Ramaswamy K; Kheterpal E; Pham H; Mohan S; Stifelman M; Taneja S; Huang WC
Clin Genitourin Cancer; 2015 Aug; 13(4):344-349. PubMed ID: 25680295
[TBL] [Abstract][Full Text] [Related]
25. Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and Predictive Factors.
Veccia A; Falagario U; Martini A; Marchioni M; Antonelli A; Simeone C; Cormio L; Capitanio U; Mir MC; Derweesh I; Van Poppel H; Porpiglia F; Autorino R
Eur Urol Focus; 2021 May; 7(3):574-581. PubMed ID: 32571744
[TBL] [Abstract][Full Text] [Related]
26. The operative safety and oncological outcomes of laparoscopic nephrectomy for T3 renal cell cancer.
Stewart GD; Ang WJ; Laird A; Tolley DA; Riddick AC; McNeill SA
BJU Int; 2012 Sep; 110(6):884-90. PubMed ID: 22289017
[TBL] [Abstract][Full Text] [Related]
27. Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics.
Erdem S; Amasyali AS; Aytac O; Onem K; Issever H; Sanli O
Urol Oncol; 2014 Oct; 32(7):1031-40. PubMed ID: 25027687
[TBL] [Abstract][Full Text] [Related]
28. Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4cm)? A propensity score-matched study.
Lee H; Oh JJ; Byun SS; Jeong CW; Kwak C; Jeong BC; Jeon SS; Lee HM; Choi HY; Seo SI
Urol Oncol; 2017 Jun; 35(6):379-385. PubMed ID: 28284894
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of preoperative kidney volume for predicting renal function in renal cell carcinoma patients receiving a radical or partial nephrectomy.
Jeon HG; Gong IH; Hwang JH; Choi DK; Lee SR; Park DS
BJU Int; 2012 May; 109(10):1468-73. PubMed ID: 21883863
[TBL] [Abstract][Full Text] [Related]
30. Computed tomography features predicting aggressiveness of malignant parenchymal renal tumors suitable for partial nephrectomy.
Ficarra V; Caloggero S; Rossanese M; Giannarini G; Crestani A; Ascenti G; Novara G; Porpiglia F
Minerva Urol Nephrol; 2021 Feb; 73(1):17-31. PubMed ID: 33200903
[TBL] [Abstract][Full Text] [Related]
31. Assessing the role of race in pathological upstaging of renal cell carcinoma: Results from the National Cancer Database.
Suss NR; Bruha MJ; Monaghan TF; Robins D; Flores V; Agudelo CW; Smith M; Hyacinthe L; McNeil BK; Weiss J; Winer A
Int J Clin Pract; 2021 Apr; 75(4):e13818. PubMed ID: 33159366
[TBL] [Abstract][Full Text] [Related]
32. Predictive Factors for Achieving Superior Pentafecta Outcomes Following Robot-Assisted Partial Nephrectomy in Patients with Localized Renal Cell Carcinoma.
Kang M; Gong IH; Park HJ; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Choi HY; Il Seo S
J Endourol; 2017 Dec; 31(12):1231-1236. PubMed ID: 29048228
[TBL] [Abstract][Full Text] [Related]
33. Pathological upstaging of clinical T1 renal cell carcinoma: an analysis of 115,835 patients from National Cancer Data Base, 2004-2013.
Ghanie A; Formica MK; Wang D; Bratslavsky G; Stewart T
Int Urol Nephrol; 2018 Feb; 50(2):237-245. PubMed ID: 29247309
[TBL] [Abstract][Full Text] [Related]
34. Mortality Increases When Radical Nephrectomy is Delayed More Than 60 Days for T3 Renal Cell Carcinoma.
Zhao F; Liu X; Zhang C; Zhu H; Qi N
Technol Cancer Res Treat; 2021; 20():15330338211043963. PubMed ID: 34595976
[No Abstract] [Full Text] [Related]
35. Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond.
Srivastava A; Patel HV; Kim S; Shinder B; Sterling J; Tabakin AL; Polotti CF; Saraiya B; Mayer T; Kim IY; Ghodoussipour S; Patel HD; Jang TL; Singer EA
Urol Oncol; 2021 May; 39(5):247-257. PubMed ID: 33223368
[TBL] [Abstract][Full Text] [Related]
36. A preoperative model to predict pT3 upstaging in clinically localized renal cell carcinoma.
de la Barra CC; González PG; Baeza MÁ; Pérez OP; Cruzat JD
Cent European J Urol; 2020; 73(2):173-177. PubMed ID: 32782837
[TBL] [Abstract][Full Text] [Related]
37. Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: a multi-institutional comparative analysis.
Oh JJ; Byun SS; Lee SE; Hong SK; Lee ES; Kim HH; Kwak C; Ku JH; Jeong CW; Kim YJ; Kang SH; Hong SH
Int J Urol; 2014 Apr; 21(4):352-7. PubMed ID: 24118633
[TBL] [Abstract][Full Text] [Related]
38. Preoperative Plasma Fibrinogen Level as a Significant Prognostic Factor in Patients With Localized Renal Cell Carcinoma After Surgical Treatment.
Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
Medicine (Baltimore); 2016 Jan; 95(4):e2626. PubMed ID: 26825920
[TBL] [Abstract][Full Text] [Related]
39. Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery.
Gofrit ON; Shapiro A; Kovalski N; Landau EH; Shenfeld OZ; Pode D
Eur Urol; 2001 Jun; 39(6):669-74; discussion 675. PubMed ID: 11464056
[TBL] [Abstract][Full Text] [Related]
40. Intraoperative allogeneic blood transfusion is associated with adverse oncological outcomes in patients with surgically treated non-metastatic clear cell renal cell carcinoma.
Kang HW; Seo SP; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Byun SS; Kim YJ;
Int J Clin Oncol; 2020 Aug; 25(8):1551-1561. PubMed ID: 32504136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
